drugset / Trial / NCT04544319
Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg
RandomizedCrossoverOpen-labelOther
Summary
To identify bioequivalence between Fixed-dose Combinations of Gemigliptin/Dapagliflozin 50/10 mg to Each Component of Gemigliptin 50 mg and Dapagliflozin 10 mg
Timeline
- Start
- 2020-10
- Primary completion
- 2021-03
- Completion
- 2021-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | — |
| Subject | Gemigliptin | Small molecule | 50 mg | — |
| Subject | Gemigliptin/Dapagliflozin | Unknown | — | — |